10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-018151`
Period End Date	20180630
Filing Date	20180731
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	nbix-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 68 Cash Flow Statement 62

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$254.71M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$166.42M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$342.32M	USD	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$261.22M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$31.13M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$42.65M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.29M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.86M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$567.68M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	90.40M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.79M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$554.92M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$18.77M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.79M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	90.40M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.81M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$247.36M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$249.39M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.48M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.50M	USD	Point-in-time
Total assets	`Assets`	$841.32M	USD	Point-in-time
Total assets	`Assets`	$817.59M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$61.03M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$53.52M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$906.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$731.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$54.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$61.76M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$8.04M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.68M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$5.33M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$3.13M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$369.62M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$378.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$463.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$445.45M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 90,403,238 as of June 30, 2018 and 88,793,903 as of December 31, 2017	`CommonStockValue`	$90.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 90,403,238 as of June 30, 2018 and 88,793,903 as of December 31, 2017	`CommonStockValue`	$89.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.57B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.63B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.81M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.20B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.25B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$377.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$841.32M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$817.59M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Product sales, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$167.99M	USD	2 Qtrs
Product sales, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$96.91M	USD	1 Quarter
Product sales, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.33M	USD	1 Quarter
Product sales, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.33M	USD	2 Qtrs
Total revenues	`Revenues`	$6.33M	USD	2 Qtrs
Total revenues	`Revenues`	$96.91M	USD	1 Quarter
Total revenues	`Revenues`	$6.33M	USD	1 Quarter
Total revenues	`Revenues`	$167.99M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsAndServicesSold`	$1.80M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsAndServicesSold`	$61.00K	USD	2 Qtrs
Cost of product sales	`CostOfGoodsAndServicesSold`	$61.00K	USD	1 Quarter
Cost of product sales	`CostOfGoodsAndServicesSold`	$854.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$36.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$85.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$21.87M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$73.75M	USD	2 Qtrs
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.91M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$41.67M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$69.72M	USD	2 Qtrs
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$119.55M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$143.53M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$98.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$63.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$207.29M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.85M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-57.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-137.20M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-39.30M	USD	2 Qtrs
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$366.00K	USD	2 Qtrs
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$183.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$879.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$1.76M	USD	2 Qtrs
Interest expense	`InterestExpense`	$4.77M	USD	1 Quarter
Interest expense	`InterestExpense`	$15.10M	USD	2 Qtrs
Interest expense	`InterestExpense`	$7.59M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.77M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$3.35M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$6.30M	USD	2 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$1.17M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$1.90M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-2.72M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.11M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-4.06M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-8.43M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.73M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-138.31M	USD	2 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.58	USD	2 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.68	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.53	USD	2 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	88,063.00	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	87,675.00	shares	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89,814.00	shares	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	90,100.00	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-47.73M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-138.31M	USD	2 Qtrs
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-395.00K	USD	2 Qtrs
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-959.00K	USD	2 Qtrs
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$888.00K	USD	1 Quarter
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-478.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-60.46M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-48.69M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-138.71M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.03M	USD	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-47.73M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-59.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-138.31M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.67M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.08M	USD	2 Qtrs
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$348.00K	USD	2 Qtrs
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$1.76M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$655.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$207.00K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$8.61M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$2.65M	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-72.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-239.00K	USD	2 Qtrs
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-544.00K	USD	2 Qtrs
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	-	USD	2 Qtrs
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.06M	USD	2 Qtrs
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-596.00K	USD	2 Qtrs
Non-cash share-based compensation expense	`ShareBasedCompensation`	$31.73M	USD	2 Qtrs
Non-cash share-based compensation expense	`ShareBasedCompensation`	$18.87M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.07M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$11.52M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.27M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$128.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.44M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.89M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.27M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$627.00K	USD	2 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$-175.00K	USD	2 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$-128.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-125.60M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.01M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$224.08M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$365.03M	USD	2 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$210.32M	USD	2 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$138.93M	USD	2 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$30.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.76M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.44M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-91.56M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-156.47M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$22.26M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.24M	USD	2 Qtrs
Proceeds from issuance of senior convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from issuance of senior convertible notes, net	`ProceedsFromConvertibleDebt`	$502.78M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.26M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$508.02M	USD	2 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-87.31M	USD	2 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$225.96M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$314.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$314.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.82M	USD	2 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$3.24M	USD	2 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.